Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits: Quantification of cellular proliferation by bromodeoxyuridine

Circulation

Volumn 94, Issue 2, 1996, Pages 175-181

  Hanke, Hartmut ^a,c   Hanke, Sybille ^a   Finking, Gerald ^b   Muhic Lohrer, Alexandra ^b   Mück, Alfred O ^b   Schmahl, Friedrich W ^b   Haasis, Rainer ^b   Hombach, Vinzenz ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Division of Cardiology   (Germany)

Author keywords

atherosclerosis; bromodeoxy uridine; hormones; hypercholesterolemia; muscle, smooth

Indexed keywords

BROXURIDINE; ESTRADIOL VALERATE; ESTROGEN; PROGESTERONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HORMONAL REGULATION; HYPERCHOLESTEROLEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RABBIT; SEX DIFFERENCE; VASCULAR SMOOTH MUSCLE;

EID: 0030004077     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.2.175     Document Type: Article

References (36)

1. McGill HC Jr, Stern MP. Sex and atherosclerosis. Atheroscler Rev. 1979;4:157-242.
2. Robinson RW, Hijano N, Cohen DB. Increased incidence of coronary heart disease in women castrated prior to the menopause. Arch Intern Med. 1959;104:908-913.
3. Parrish HM, Carr CA, Hall DG, King TM. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol. 1967;99:155-162.
4. Ludden JB, Bruger M, Wright IS. Experimental atherosclerosis, IV: effect of testosterone propionate and estradiol dipropionate on experimental atherosclerosis in rabbits. Arch Pathol. 1942;33:58-62.
5. Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 1985;7:89-104.
6. Sullivan JM, Vander Zwaag R, Lemp GF, Hughes JP, Madock V, Kroetz FW, Ramanathan KB, Mirvis DM. Postmenopausal use and coronary atherosclerosis. Ann Intern Med. 1988;108:358-363.
7. Stampfer MJ, Golditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
8. Avila MH, Walker AM, Jick H. Use of replacement estrogens and the risk of myocardial infarction. Epidemiology. 1990;1:128-133.
9. Hough JL, Zilversmit DB. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis, 1986;6:57-63.
10. Hanash KA, Kottke BA, Greene LF, Titus JL. Effects of conjugated estrogens on spontaneous atherosclerosis in pigeons. Arch Pathol. 1972;93:184-189.
11. Fischer GM, Swain ML. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis. 1985:54:177-185.
12. Negre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R. Protective effect of 17β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 1993;99:207-217.
13. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
14. Haarbo J, Leth-Espensen P, Slender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
15. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by oestrogen: a calcium antagonist effect? Lancet. 1993;341:1264-1265.
16. Muck AO, Seeger H, Hanke H, Hanke S, Haasis R, Lippert TH. Effects of estradiol and gestagens on calcium-homeostasis in human aortic vessels. Menopause. 1994;3:165. Abstract.
17. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental balloon angioplasty. Circ Res. 1990;67:651-659.
18. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89:1943-1950.
19. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of prernenopausal women. Circulation. 1994;89:1501-1510.
20. Guesdon JL, Ternyck T. Avrameas S. The use of avidin biotin interaction in immunoenzymatic techniques. J Histochem Cytochem. 1979;27:771-776.
21. Gabbiani G, Kocher O, Bloom WS. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 1984;74:148-152.
22. Vandekerckhove J, Weber K. The complete amino acid sequence of actins from bovine aorta, bovine heart, bovine fast skeletal muscle, and rabbit slow skeletal muscle. Differentiation. 1979;14:123-133.
23. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovarectomized monkeys. Arteriosclerosis. 1990;10:1051-1057.
24. Kushwaha RS, Hazzard WR. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism. 1981;30:359-366.
25. Pick R, Stamler J, Rodbard S, Katz LN. The inhibition of coronary atherosclerosis by estrogens in cholesterol-fed chicks. Circulation. 1952;6:276-280.
26. Anitschkow N. Über die Atheroskerose der Aorta beim Kaninchen und über deren Entstehungsbedingungen. Beitr Path Anatomie u Allgem Path. 1914;59:306-348.
27. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczalusy U, Berglund L, Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterolfed rabbit. Eur J Clin Invest. 1989;19:395-403.
28. Bocan TMA, Mueller SB, Mazur MJ, Uhlendorf PD, Brown EQ, Kieft KA. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis. 1993;102:9-22.
29. McMillan GC, Duff GL. Mitotic activity in the aortic lesions of experimental atherosclerosis in rabbits. Arch Pathol. 1948;46:179-182.
30. Stary HC, McMillan GC. Kinetics of cellular proliferation in experimental atherosclerosis: radioautography with grain counts in cholesterol-fed rabbits. Arch Pathol. 1970;89:173-183.
31. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1990;10:680-687.
32. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
33. Lin AL, Gonzalez Jr R, Carey KD, Shain SA. Estradiol-17β affects estrogen receptor distribution and elevates progesterone receptor content in the babboon aorta. Arteriosclerosis. 1986;6:495-504.
34. Ingegno MD, Money SR, Thelmo W, Greene GL, Davidian M, Jaffe BM, Pertschuk LP. Progesterone receptors in human heart and great vessels. Lab Invest. 1988;59:353-356.
35. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen. responsive cells in culture. Proc Natl Acad Sci USA. 1986;83:2496-2500.
36. Welshons WV, Wolf MF, Murphy CS, Jordan VC. Estrogenic activity of phenol red. Mol Cell Endocrinol. 1988;57:169-178.